quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:09·102d
SECFiling
Cidara Therapeutics Inc. logo

SEC Form EFFECT filed by Cidara Therapeutics Inc.

CDTX· Cidara Therapeutics Inc.
Health Care
Original source

Companies

  • CDTX
    Cidara Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Nov 17UpdateMorgan Stanley-
  • Nov 17UpdateAnalyst-
  • Nov 17UpdateRBC Capital Mkts-
  • Oct 16UpdateMorgan Stanley$190.00
  • Oct 10UpdateAnalyst$200.00
  • Jun 18UpdateH.C. Wainwright$41.00

Related

  • SEC93d
    SEC Form 15-12G filed by Cidara Therapeutics Inc.
  • SEC102d
    SEC Form EFFECT filed by Cidara Therapeutics Inc.
  • SEC102d
    SEC Form EFFECT filed by Cidara Therapeutics Inc.
  • SEC102d
    SEC Form EFFECT filed by Cidara Therapeutics Inc.
  • SEC102d
    SEC Form EFFECT filed by Cidara Therapeutics Inc.
  • SEC102d
    SEC Form EFFECT filed by Cidara Therapeutics Inc.
  • INSIDER104d
    Director Ra Capital Management, L.P. exercised 1,286,786 shares at a strike of $0.00 and returned $1,030,486,444 worth of shares to the company (4,652,309 units at $221.50) (SEC Form 4)
  • SEC104d
    Amendment: SEC Form SCHEDULE 13D/A filed by Cidara Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022